Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency
Unlike short-acting medications that require precise timing around meals, semaglutide doesn't depend on food presence to work
Regulation of mitochondrial fatty acid beta-oxidation in human: what can we learn from inborn fatty acid beta-oxidation deficiencies
However, severe side effects are rare, and most side effects can be managed by starting at a lower dose and gradually increasing as tolerated
Contact your healthcare provider promptly to assess symptoms and adjust treatment if necessary
What the Pivotal Trial Actually Measured STEP 1 enrolled 1,961 adults with a body mass index of 30 or greater, or 27 or greater with at least one weight-related coexisting condition, none of whom had diabetes